These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14139998)

  • 41. [PHARMACOLOGY OF CORONARY VASODILATOR AGENTS].
    HASHIMOTO T
    Sogo Rinsho; 1964 Mar; 13():445-51. PubMed ID: 14140831
    [No Abstract]   [Full Text] [Related]  

  • 42. Increase in myocardial collateral capacity following drug-induced coronary vasodilatation. A preliminary report.
    Rees JR; Redding VJ
    Am Heart J; 1969 Aug; 78(2):224-8. PubMed ID: 4894487
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug-induced augmentation of coronary flow in vessels with maximum ischemic dilatation.
    Csik V; Szekeres L; Udvary E
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):66-76. PubMed ID: 827991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrograde flow technique vs. krypton-85 clearance technique for estimation of myocardial collaterals.
    Cibulski AA; Lehan PH; Timmis HH
    Am J Physiol; 1972 Nov; 223(5):1081-7. PubMed ID: 4654342
    [No Abstract]   [Full Text] [Related]  

  • 45. Correlation of transthoracic Doppler echocardiography and magnetic resonance imaging in measuring left anterior descending artery flow velocity and time-course of dipyridamole-induced coronary flow increase.
    Koskenvuo JW; Saraste M; Niemi P; Knuuti J; Sakuma H; Toikka JO; Komu M; Järvisalo MJ; Hartiala JJ
    Scand J Clin Lab Invest; 2003; 63(1):65-72. PubMed ID: 12729071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Collateral influence on pressure-flow characteristics of coronary circulation.
    Scheel KW; Mass H; Williams SE
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H717-25. PubMed ID: 2782430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microvascular occlusions promote coronary collateral growth.
    Chilian WM; Mass HJ; Williams SE; Layne SM; Smith EE; Scheel KW
    Am J Physiol; 1990 Apr; 258(4 Pt 2):H1103-11. PubMed ID: 2330998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of 2,6-bis(diethanolamino)-4-piperidino-pyrimido(5,4-D)pyrimidine (RA233) on the coronary circulation of the acutely transplanted dog heart: comparison with dipyridamole and adenosine.
    Paoloni HJ; Wilcken DE
    J Pharmacol Exp Ther; 1972 Oct; 183(1):137-45. PubMed ID: 4562619
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of drugs and sympathetic nerve stimuation on retrograde coronary blood flow in dogs with experimental coronary occlusion.
    Takenaka F; Matuo M; Ishihara T
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):75-85. PubMed ID: 239650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of coronary artery volume flow rate using fast velocity-encoded cine MR imaging.
    Sakuma H; Saeed M; Takeda K; Wendland MF; Schwitter J; Szolar DH; Derugin N; Shimakawa A; Foo TK; Higgins CB
    AJR Am J Roentgenol; 1997 May; 168(5):1363-7. PubMed ID: 9129446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sympathetic influences on the native canine coronary collateral circulation.
    Euler DE
    Cardiovasc Res; 1995 Jan; 29(1):33-7. PubMed ID: 7895236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of coronary vasodilating action of dipyridamole and adenosine by aminophylline in the dog.
    Afonso S
    Circ Res; 1970 Jun; 26(6):743-52. PubMed ID: 4987265
    [No Abstract]   [Full Text] [Related]  

  • 53. Detection of moderate regional ischemia in pig hearts in vivo by near-infrared and thermal imaging: effects of dipyridamole.
    Kupriyanov VV; Manley DM; Xiang B
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):113-23. PubMed ID: 17431819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of theo-esberiven on the development of collateral circulation in dog hearts.
    Sakai K; Sakanashi M; Mizusawa H; Takenaka F; Takeshita S
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):104-14. PubMed ID: 543741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EVALUATION OF A CORONARY VASODILATOR, DIPYRIDAMOLE (PERSANTIN).
    HARDY JD; KURRUS FD; CHAVEZ CM; NEELY WA; ERASLAN S; TURNER MD; FABIAN LW; LABECKI TD
    JAMA; 1964 Jun; 188():1141. PubMed ID: 14163111
    [No Abstract]   [Full Text] [Related]  

  • 56. Chronic oral dipyridamole as a 'novel' antianginal drug: the collateral hypothesis.
    Picano E; Michelassi C
    Cardiovasc Res; 1997 Mar; 33(3):666-70. PubMed ID: 9093537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IMPLANTATION OF THE SPLENIC ARTERY INTO THE MYOCARDIUM AS A SOURCE OF COLLATERAL CIRCULATION.
    BLOOMER WE; VIDONE RA; LIEBOW AA
    Yale J Biol Med; 1964 Feb; 36(4):295-305. PubMed ID: 14119863
    [No Abstract]   [Full Text] [Related]  

  • 58. THE EFFECT OF SODIUM NITROPRUSSIDE ON CORONARY CIRCULATION.
    TOUNTAS CJ; GEORGOPOULOS AJ; KYRIAKOU KV; MARSELOS AA
    Bull Soc Int Chir; 1964; 23():267-73. PubMed ID: 14179508
    [No Abstract]   [Full Text] [Related]  

  • 59. [5,4-d] pyrimidine (Persantin)].
    BETZ E; BRAASCH D; HENSEL H
    Verh Dtsch Ges Kreislaufforsch; 1961; 27():321-6. PubMed ID: 13868680
    [No Abstract]   [Full Text] [Related]  

  • 60. [ROLE OF INTERCORONARY ANASTOMOSES IN THE BLOOD SUPPLY OF THE MYOCARDIUM IN DISORDERS OF THE CORONARY CIRCULATION].
    GRACHEV AM
    Eksp Khir Anesteziol; 1964; 29():7-11. PubMed ID: 14161503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.